Detailansicht

Wissensnetz

Person

Elke Pfaff (1985-)

Name	Elke Pfaff
Zeit	1985- (Lebensdaten)
Ort	Tübingen (Geburtsort) Deutschland
Geschlecht	weiblich
Akademischer Grad bzw. Titel	Dr. (an der Medizinischen Fakultät der Universität Heidelberg) (2012)
Variante	Elke Katrin Pfaff
Datensatztyp	Person
GND-Nummer	1037262174
Datensatz-ID	1037262174
Beteiligt an alle anzeigen Genetical and epigenetical profiling identifies two subgroups of pineal parenchymal tumors of intermediate differentiation (PPTID) with distinct molecular, histological and clinical characteristics The pediatric precision oncology INFORM registry: clinical outcome and benefit for patients with very high-evidence targets INFORM2 NivEnt: The first trial of the INFORM2 biomarker driven phase I/II trial series: the combination of nivolumab and entinostat in children and adolescents with refractory high-risk malignancies Molecular subgrouping of primary pineal parenchymal tumors reveals distinct subtypes correlated with clinical parameters and genetic alterations Recurrent homozygous deletion of DROSHA and microduplication of PDE4DIP in pineoblastoma Author Correction: The landscape of genomic alterations across childhood cancers The landscape of genomic alterations across childhood cancers New brain tumor entities emerge from molecular classification of CNS-PNETs Next-generation personalised medicine for high-risk paediatric cancer patients – the INFORM pilot study Dissecting the genomic complexity underlying medulloblastoma Prognostic and predictive value of TP53 mutations in pediatric medulloblastoma

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Elke Pfaff (1985-)

Genetical and epigenetical profiling identifies two subgroups of pineal parenchymal tumors of intermediate differentiation (PPTID) with distinct molecular, histological and clinical characteristics

The pediatric precision oncology INFORM registry: clinical outcome and benefit for patients with very high-evidence targets

INFORM2 NivEnt: The first trial of the INFORM2 biomarker driven phase I/II trial series: the combination of nivolumab and entinostat in children and adolescents with refractory high-risk malignancies

Molecular subgrouping of primary pineal parenchymal tumors reveals distinct subtypes correlated with clinical parameters and genetic alterations

Recurrent homozygous deletion of DROSHA and microduplication of PDE4DIP in pineoblastoma

Author Correction: The landscape of genomic alterations across childhood cancers

The landscape of genomic alterations across childhood cancers

New brain tumor entities emerge from molecular classification of CNS-PNETs

Next-generation personalised medicine for high-risk paediatric cancer patients – the INFORM pilot study

Dissecting the genomic complexity underlying medulloblastoma

Prognostic and predictive value of TP53 mutations in pediatric medulloblastoma